A detailed history of Cwm, LLC transactions in Grifols Sa stock. As of the latest transaction made, Cwm, LLC holds 327 shares of GRFS stock, worth $2,354. This represents 0.0% of its overall portfolio holdings.

Number of Shares
327
Previous 289 13.15%
Holding current value
$2,354
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$6.28 - $9.38 $238 - $356
38 Added 13.15%
327 $3,000
Q2 2024

Jul 09, 2024

BUY
$6.27 - $7.7 $1,047 - $1,285
167 Added 136.89%
289 $2,000
Q1 2024

Apr 05, 2024

SELL
$5.47 - $11.38 $3,506 - $7,294
-641 Reduced 84.01%
122 $1,000
Q4 2023

Feb 01, 2024

BUY
$7.71 - $11.56 $370 - $554
48 Added 6.71%
763 $9,000
Q3 2023

Oct 11, 2023

BUY
$8.91 - $10.91 $1,790 - $2,192
201 Added 39.11%
715 $7,000
Q2 2023

Aug 03, 2023

BUY
$7.14 - $9.29 $2,013 - $2,619
282 Added 121.55%
514 $5,000
Q1 2023

Apr 28, 2023

BUY
$6.65 - $10.69 $53 - $85
8 Added 3.57%
232 $2,000
Q4 2022

Feb 01, 2023

SELL
$5.96 - $8.53 $3,295 - $4,717
-553 Reduced 71.17%
224 $2,000
Q3 2022

Oct 27, 2022

BUY
$5.95 - $14.3 $1,076 - $2,588
181 Added 30.37%
777 $5,000
Q2 2022

Jul 28, 2022

BUY
$10.6 - $13.28 $625 - $783
59 Added 10.99%
596 $7,000
Q1 2022

Apr 21, 2022

SELL
$10.37 - $12.73 $3,225 - $3,959
-311 Reduced 36.67%
537 $6,000
Q4 2021

Jan 31, 2022

BUY
$10.21 - $15.27 $6,544 - $9,788
641 Added 309.66%
848 $10,000
Q1 2021

Sep 15, 2021

SELL
$15.15 - $19.78 $1,802 - $2,353
-119 Reduced 36.5%
207 $4,000
Q1 2021

Apr 27, 2021

BUY
$15.15 - $19.78 $1,802 - $2,353
119 Added 57.49%
326 $6,000
Q4 2020

Sep 15, 2021

BUY
$16.86 - $19.67 $1,888 - $2,203
112 Added 117.89%
207 $4,000
Q4 2020

Jan 27, 2021

SELL
$16.86 - $19.67 $1,888 - $2,203
-112 Reduced 54.11%
95 $2,000
Q3 2020

Sep 15, 2021

SELL
$15.4 - $20.16 $723 - $947
-47 Reduced 18.5%
207 $4,000
Q3 2020

Oct 19, 2020

BUY
$15.4 - $20.16 $723 - $947
47 Added 22.71%
254 $4,000
Q2 2020

Sep 15, 2021

SELL
$18.24 - $21.45 $594,186 - $698,755
-32,576 Reduced 99.37%
207 $4,000
Q2 2020

Jul 22, 2020

BUY
$18.24 - $21.45 $594,186 - $698,755
32,576 Added 15737.2%
32,783 $598,000
Q1 2020

Sep 15, 2021

SELL
$16.28 - $25.63 $728,497 - $1.15 Million
-44,748 Reduced 99.54%
207 $4,000
Q1 2020

Apr 28, 2020

BUY
$16.28 - $25.63 $728,497 - $1.15 Million
44,748 Added 21617.39%
44,955 $905,000
Q4 2019

Sep 14, 2021

SELL
$19.57 - $23.52 $1.1 Million - $1.32 Million
-56,122 Reduced 99.63%
207 $4,000
Q4 2019

Jan 27, 2020

BUY
$19.57 - $23.52 $1.1 Million - $1.32 Million
56,122 Added 27112.08%
56,329 $1.31 Million
Q3 2019

Sep 14, 2021

SELL
$19.85 - $22.76 $1.77 Million - $2.03 Million
-89,378 Reduced 99.77%
207 $4,000
Q3 2019

Oct 22, 2019

BUY
$19.85 - $22.76 $1.77 Million - $2.03 Million
89,378 Added 43177.78%
89,585 $1.8 Million
Q2 2019

Sep 14, 2021

SELL
$17.59 - $21.1 $2.08 Million - $2.49 Million
-118,142 Reduced 99.83%
207 $4,000
Q2 2019

Jul 31, 2019

BUY
$17.59 - $21.1 $2.08 Million - $2.49 Million
118,142 Added 57073.43%
118,349 $2.5 Million
Q1 2019

Sep 02, 2021

SELL
$18.01 - $20.11 $2.24 Million - $2.5 Million
-124,489 Reduced 99.83%
207 $0
Q1 2019

Apr 22, 2019

SELL
$18.01 - $20.11 $139,703 - $155,993
-7,757 Reduced 5.86%
124,696 $2.51 Million
Q4 2018

Jan 25, 2019

SELL
$17.44 - $21.53 $171,051 - $211,166
-9,808 Reduced 6.89%
132,453 $2.43 Million
Q3 2018

Oct 29, 2018

BUY
$19.97 - $21.96 $684,152 - $752,327
34,259 Added 31.72%
142,261 $3.04 Million
Q2 2018

Jul 31, 2018

BUY
$20.16 - $24.68 $604,920 - $740,548
30,006 Added 38.47%
108,002 $2.32 Million
Q1 2018

Apr 26, 2018

BUY
$20.31 - $24.95 $336,313 - $413,147
16,559 Added 26.95%
77,996 $1.65 Million
Q4 2017

Jan 16, 2018

SELL
$20.99 - $23.89 $850,556 - $968,070
-40,522 Reduced 39.74%
61,437 $1.41 Million
Q3 2017

Oct 16, 2017

BUY
$20.07 - $21.89 $2.05 Million - $2.23 Million
101,959
101,959 $2.23 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $4.89B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.